Yadah Hotel’s acquittal was not an endorsement of Opti-MSM

Yadah Hotel was reportedly acquitted of charges concerning unregistered medicines because the prosecution failed to establish its case. The reported ruling does not establish that MSM is safe, effective or approved. Opti-MSM appeared in the reported list of allegedly recovered products. That mention should not be read as either a product endorsement or proof of illegality.

ZimLive’s September 25, 2026 report and NewZimbabwe’s account agree on the central outcome: the hotel was discharged at the close of the State’s case after insufficient evidence linked it to the medicines. These accounts are court reports, not the written judgment or a product-authorization record.

What the court reportedly decided

Yadah Hotel, described in the reports as owned by Walter Magaya, faced two counts under Zimbabwe’s Medicines and Allied Substances Control Act. These concerned alleged possession of unregistered medicines and unregistered complementary medicines at its Waterfalls premises in Harare.

The prosecution alleged that detectives searched the hotel on November 1, 2025 and recovered products from one room. According to ZimLive, Harare magistrate Lisa Mutendereki discharged the hotel at the close of the prosecution’s case.

The reports identify two evidence gaps:

• Possession: the State had not sufficiently connected the recovered medicines to Yadah Hotel.
• Regulatory status: the State had not produced evidence from the relevant medicines regulatory authority establishing that the seized products were not registered or regulated in Zimbabwe.

NewZimbabwe reports that the prosecution ended without the hotel being put on its defence. The reported defendant and acquittal were Yadah Hotel’s; these accounts do not describe an MSM manufacturer being tried or cleared.

Where Opti-MSM fits—and what remains unidentified

Both reports list a product described as “High Purity Methane Inflammation Opti-MSM Methylsulfonylmethane” among the items allegedly recovered. Other listed products included cotrimoxazole, fluconazole and liquid glutathione. This is the wording of the reported allegation, not an independently verified product specification.

Neither account supplies a label photograph, manufacturer confirmation, batch number or laboratory certificate for the MSM item. The name alone therefore does not establish its authenticity, composition, purity or ingredient supplier. Nor does the phrase “High Purity” amount to test evidence.

The distinction matters: failure to prove that a product was unregistered is not an affirmative finding that it was registered. Similarly, failure to link products to the hotel does not answer whether those products work or are suitable for a particular consumer. These news accounts describe evidentiary findings, not a clinical assessment of MSM.

What MSM buyers should check instead

If someone uses this ruling to promote an MSM supplement, ask for evidence about the exact product rather than a court headline:

• Identity and quality: a complete label, identifiable manufacturer and batch-specific test documentation.
• Zimbabwe authorization: confirmation of the finished product’s applicable registration or approval status. The Medicines Control Authority of Zimbabwe’s registered-and-approved medicines page explains that approved or registered products are published in its drug register and links to that register. Ask MCAZ to clarify an uncertain match.
• Health claims: human-study evidence relevant to the formulation, dose, population and claimed outcome—not the hotel’s acquittal.

For the separate supplement question, see our OptiMSM evidence, safety and quality guide. The reported Yadah Hotel ruling concerns a failed prosecution against the hotel; it does not replace product verification or evidence of benefit.